CLEVELAND, Ohio — More people are taking GLP-1 drugs like Ozempic, Wegovy and Mounjaro to lose weight and control Type 2 diabetes. But when people stop taking them, extra pounds can quickly return. In ...

Context Explanation

NDTV on MSN: Ozempic might preserve lean body mass better than Mounjaro: Study GLP-1 receptor agonists — such as semaglutide (Ozempic and Wegovy), and tirzepatide (Mounjaro and Zepbound) — have been most commonly associated with gastrointestinal side effects, such as nausea, ... The Indian Express: Not losing weight on Mounjaro or Ozempic? Your genes could be the reason, says new study Not losing weight on Mounjaro or Ozempic? Your genes could be the reason, says new study GB News on MSN: Ozempic and Mounjaro linked to possible 'unrecognised' side effects in study of 70,000 users Weight-loss injections such as Ozempic and Mounjaro may cause side effects that pharmaceutical companies have not included on their official labels, according to new research.

Insight Material

An analysis published in ... Ozempic and Mounjaro linked to possible 'unrecognised' side effects in study of 70,000 users